[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Stanley et al., 2015 - Google Patents

Remote regulation of glucose homeostasis in mice using genetically encoded nanoparticles

Stanley et al., 2015

View HTML
Document ID
13296958594326607271
Author
Stanley S
Sauer J
Kane R
Dordick J
Friedman J
Publication year
Publication venue
Nature medicine

External Links

Snippet

Means for temporally regulating gene expression and cellular activity are invaluable for elucidating underlying physiological processes and would have therapeutic implications. Here we report the development of a genetically encoded system for remote regulation of …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Similar Documents

Publication Publication Date Title
Stanley et al. Remote regulation of glucose homeostasis in mice using genetically encoded nanoparticles
Stanley et al. Bidirectional electromagnetic control of the hypothalamus regulates feeding and metabolism
Wheeler et al. Genetically targeted magnetic control of the nervous system
Rao et al. Remotely controlled chemomagnetic modulation of targeted neural circuits
Bacaj et al. Synaptotagmin-1 and-7 are redundantly essential for maintaining the capacity of the readily-releasable pool of synaptic vesicles
Rivetti Di Val Cervo et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model
US12005265B2 (en) Compositions and methods to modulate cell activity
US10786570B2 (en) Ferritin nanoparticle compositions and methods to modulate cell activity
Dai et al. GluD1 is a signal transduction device disguised as an ionotropic receptor
Economopoulou et al. Histone H2AX is integral to hypoxia-driven neovascularization
Arenkiel et al. Genetic control of neuronal activity in mice conditionally expressing TRPV1
Yamaguchi et al. Heat-inducible gene expression system by applying alternating magnetic field to magnetic nanoparticles
Tasaka et al. Semaphorin 4D/Plexin-B1-mediated M-Ras GAP activity regulates actin-based dendrite remodeling through Lamellipodin
Harcha et al. Hemichannels are required for amyloid β-peptide-induced degranulation and are activated in brain mast cells of APPswe/PS1dE9 mice
Jiang et al. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β
Hayashi et al. An intermediate-conductance Ca2+-activated K+ channel is important for secretion in pancreatic duct cells
Tang et al. SUMOylation of synapsin Ia maintains synaptic vesicle availability and is reduced in an autism mutation
Mosabbir et al. Genetically encoded circuit for remote regulation of cell migration by magnetic fields
Zhang et al. Optogenetic regulation of insulin secretion in pancreatic β-cells
Brier et al. Uncovering a possible role of reactive oxygen species in magnetogenetics
Zhan et al. FMRP (1–297)-tat restores ion channel and synaptic function in a model of Fragile X syndrome
Sanchez‐Rodriguez et al. Plasmonic activation of gold nanorods for remote stimulation of calcium signaling and protein expression in HEK 293T cells
Gibb et al. Lyn kinase regulates mesolimbic dopamine release: implication for alcohol reward
Calo et al. CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice
Shinoda et al. CAPS1 stabilizes the state of readily releasable synaptic vesicles to fusion competence at CA3–CA1 synapses in adult hippocampus